• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    55 Biggest Movers From Friday

    4/25/22 4:23:55 AM ET
    $ALVR
    $AMPE
    $AMYT
    $ATEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ALVR alert in real time by email

    Gainers

    • Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) shares jumped 100.9% to close at $2.27 on Friday. Vallon Pharmaceuticals engaged Ladenburg Thalmann & Co Inc to evaluate strategic alternatives for the Company to maximize shareholder value.
    • Blueknight Energy Partners, L.P. (NASDAQ:BKEP) shares gained 38.6% to close at $4.56 on Friday after the company announced it will be acquired by its general partner Ergon.
    • Moving iMage Technologies, Inc. (NASDAQ:MITQ) gained 38.3% to close at $1.59. Moving iMage Technologies and SNDBX reported a strategic partnership for gaming and e-Sports.
    • Cyngn Inc. (NASDAQ:CYN) gained 26.9% to settle at $2.69. Cyngn recently announced the official launch of DriveMod Kit, a turnkey autonomous vehicle solution.
    • Sky Harbour Group Corporation (NYSE:SKYH) jumped 26.3% to close at $8.01 on abnormally-high volume.
    • Forge Global Holdings, Inc. (NYSE:FRGE) gained 20% to settle at $14.04 on below-average volume.
    • Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) rose 18.6% to close at $1.21.
    • DURECT Corporation (NASDAQ:DRRX) jumped 15.6% to settle at $0.4739.
    • Evelo Biosciences, Inc. (NASDAQ:EVLO) rose 15.3% to close at $2.41. Evelo Biosciences recently said it will put the EDP1867 program on hold after completing a Phase 1 clinical trial in atopic dermatitis.
    • GWG Holdings, Inc. (NASDAQ:GWGH) gained 15% to settle at $2.30.
    • Amryt Pharma plc (NASDAQ:AMYT) jumped 14.6% to close at $8.87 after the European Medicines Agency's Committee for Medicinal Products for Human Use recommended the approval of Filsuvez in the European Union for the treatment of epidermolysis bullosa.
    • Ampio Pharmaceuticals, Inc. (NYSE:AMPE) rose 13.6% to close at $0.2815. Ampio Pharmaceuticals shares dropped 27% on Thursday after the company provided a regulatory update and said the FDA did not agree with the company's proposed changes to its AP-013 trial.
    • Harbor Custom Development, Inc. (NASDAQ:HCDI) rose 13% to settle at $2.53. Harbor Custom Development recently restated its earnings.
    • Gelesis Holdings, Inc. (NYSE:GLS) jumped 12.9% to close at $4.90 on below-average volume.
    • FAT Brands Inc. (NASDAQ:FAT) gained 11.7% to close at $6.13.
    • Chindata Group Holdings Limited (NASDAQ:CD) shares gained 9.8% to close at $4.81 after Bloomberg reported the company had received early takeover interest from other companies in the industry.
    • A10 Networks, Inc. (NYSE:ATEN) gained 9.4% to close at $14.44 after it was announced the company is set to join the S&P SmallCap 600.
    • Kimberly-Clark Corporation (NYSE:KMB) jumped 8.1% to settle at $138.51 after the company reported better-than-expected Q1 adjusted EPS and sales results.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) gained 8% to close at $41.00 after dropping over 17% on Thursday.
    • SVB Financial Group (NASDAQ:SIVB) gained 7.5% to close at $541.04 after the company reported better-than-expected Q1 EPS results and raised its FY22 revenue guidance.

     

    Losers

    • Babylon Holdings Limited (NYSE:BBLN) shares tumbled 52.7% to close at $1.75 on Friday. The company is scheduled to report Q1 results on May 12, 2022.
    • Dogness (International) Corporation (NASDAQ:DOGZ) dipped 46% to settle at $3.51.
    • ION Geophysical Corporation (NYSE:IO) shares tumbled 27.9% to close at $0.4703. ION Geophysical recently announced it has been awarded a five-year contract by Brunei Shell Petroleum for a digital solution to manage Marine Logistics.
    • BigBear.ai Holdings, Inc. (NYSE:BBAI) fell 27.5% to close at $8.55.
    • FedNat Holding Company (NASDAQ:FNHC) fell 26.5% to close at $0.5345 on continued weakness following Thursday comments from Fed Chair Powell suggesting a rate hike of 50 basis points is possible for May.
    • SCYNEXIS, Inc. (NASDAQ:SCYX) dipped 25.8% to close at $2.33. SCYNEXIS announced interim data from its ongoing Phase 3 FURI and CARES studies of ibrexafungerp in severe fungal infections. The company also reported pricing of $45 million public offering of common stock, pre-funded warrants and warrants.
    • Pulse Biosciences, Inc. (NASDAQ:PLSE) fell 25.7% to close at $3.18. Pulse BioSciences recently reported rights offering for $15 million in units.
    • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) fell 22.1% to close at $1.80 after gaining 11% on Thursday. The company on Tuesday announced it will present new data on JATENZO at the Androgen Society 4th Annual Meeting.
    • HCA Healthcare, Inc. (NYSE:HCA) fell 21.8% to close at $210.64 after the company reported worse-than-expected Q1 adjusted EPS results and cut FY22 guidance.
    • Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) dropped 20.5% to close at $0.2701 after the company announced a $2.3 million registered direct offering.
    • NACCO Industries, Inc. (NYSE:NC) fell 19.4% to settle at $40.00.
    • Onion Global Limited (NYSE:OG) dipped 19.3% to close at $1.51.
    • Value Line, Inc. (NASDAQ:VALU) dipped 19.2% to close at $61.70.
    • Enjoy Technology, Inc. (NASDAQ:ENJY) fell 19% to settle at $2.09.
    • Cuentas Inc. (NASDAQ:CUEN) fell 18.6% to close at $1.01.
    • The Gap, Inc. (NYSE:GPS) fell 18% to close at $11.72 after the company said Nancy Green, CEO and president of its largest brand, Old Navy, is departing this week. Gap also lowered its quarterly forecast.
    • Community Health Systems, Inc. (NYSE:CYH) fell 17.9% to close at $9.43.
    • SciSparc Ltd. (NASDAQ:SPRC) dropped 17.7% to settle at $2.70 on below-average volume.
    • Surgery Partners, Inc. (NASDAQ:SGRY) declined 16.7% to close at $50.12.
    • AlloVir, Inc. (NASDAQ:ALVR) fell 16.6% to close at $4.52. AlloVir recently announced the FDA granted Regenerative Medicine Advanced Therapy designation to its posoleuce for the prevention of infections from six viruses in allogeneic hematopoietic cell transplant patients.
    • Plus Therapeutics, Inc. (NASDAQ:PSTV) dipped 16% to close at $0.7430. Plus Therapeutics recently posted Q1 loss of $0.19 per share.
    • Tenet Healthcare Corporation (NYSE:THC) dropped 15.7% to close at $73.11. Tenet Healthcare recently said Q1 FY22 adjusted EPS came in at $1.93, up from $1.30 a year ago and beating the management guidance of $0.92 - $1.15.
    • Sharps Technology, Inc. (NASDAQ:STSS) fell 14.8% to close at $1.49.
    • Global Internet of People, Inc. (NASDAQ:SDH) dipped 14.7% to settle at $2.03.
    • Intuitive Surgical, Inc. (NASDAQ:ISRG) fell 14.3% to close at $252.34 after the company reported Q1 earnings results.
    • Universal Health Services, Inc. (NYSE:UHS) dipped 14% to close at $132.93 ahead of quarterly earnings.
    • Sientra, Inc. (NASDAQ:SIEN) fell 13.9% to settle at $1.42.
    • Lantronix, Inc. (NASDAQ:LTRX) dipped 14.2% to close at $5.52.
    • Locafy Limited (NASDAQ:LCFY) dropped 13.4% to settle at $1.23.
    • Globus Medical, Inc. (NYSE:GMED) fell 13.3% to close at $68.53. Globus Medical announced the resignation of President and CEO Dave Demski after nearly 20 years with the company, with the last four and a half years as its CEO. The company also expects Q1 FY22 sales of approximately $230.5 million, up 1.4% Y/Y, compared to the consensus of $235.94 million.
    • Corsair Gaming, Inc. (NASDAQ:CRSR) shares fell 11.8% to close at $16.15 after the company issued Q1 revenue guidance below analyst estimates.
    • Herc Holdings Inc. (NYSE:HRI) fell 10.5% to close at $132.02. The company recently posted mixed quarterly results.
    • Lands' End, Inc. (NYSE:LE) fell 9.3% to close at $14.51 after Craig-Hallum downgraded the stock from Buy to Hold and lowered its price target from $35 to $15.
    • Camber Energy, Inc. (NYSE:CEI) fell 8.9% to close at $0.8298 after dropping more than 10% on Thursday.
    • Genfit SA (NASDAQ:GNFT) shares fell 8.3% to close at $3.75.
    Get the next $ALVR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALVR
    $AMPE
    $AMYT
    $ATEN

    CompanyDatePrice TargetRatingAnalyst
    PLUS THERAPEUTICS Inc.
    $PSTV
    2/3/2026$2.00Buy
    Lake Street
    Globus Medical Inc.
    $GMED
    1/30/2026$112.00Hold → Buy
    Needham
    Pulse Biosciences Inc
    $PLSE
    1/30/2026$25.00Outperform
    Mizuho
    Intuitive Surgical Inc.
    $ISRG
    1/27/2026$660.00Buy
    TD Cowen
    Globus Medical Inc.
    $GMED
    1/27/2026$110.00Buy
    TD Cowen
    Universal Health Services Inc.
    $UHS
    1/7/2026$235.00Overweight → Equal Weight
    Wells Fargo
    BigBear.ai Inc.
    $BBAI
    1/7/2026$6.00Overweight → Neutral
    Cantor Fitzgerald
    Herc Holdings Inc.
    $HRI
    12/17/2025$200.00Sector Weight → Overweight
    KeyBanc Capital Markets
    More analyst ratings

    $ALVR
    $AMPE
    $AMYT
    $ATEN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Sainz Maria

    4 - PULSE BIOSCIENCES, INC. (0001625101) (Issuer)

    2/6/26 9:21:10 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Sainz Maria

    3 - PULSE BIOSCIENCES, INC. (0001625101) (Issuer)

    2/6/26 9:18:07 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    Director Maclin Todd transferred by will 134 shares) and bought $38,775 worth of shares (266 units at $145.77), increasing direct ownership by 20% to 2,400 units (SEC Form 4)

    4 - KIMBERLY CLARK CORP (0000055785) (Issuer)

    2/6/26 5:27:22 PM ET
    $KMB
    Containers/Packaging
    Consumer Discretionary

    $ALVR
    $AMPE
    $AMYT
    $ATEN
    SEC Filings

    View All

    Moving iMage Technologies Inc. filed SEC Form 8-K: Shareholder Director Nominations

    8-K - MOVING iMAGE TECHNOLOGIES INC. (0001770236) (Filer)

    2/6/26 12:36:28 PM ET
    $MITQ
    Industrial Machinery/Components
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by Surgery Partners Inc.

    SCHEDULE 13G/A - Surgery Partners, Inc. (0001638833) (Subject)

    2/5/26 1:40:12 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    SEC Form 10-Q filed by Lantronix Inc.

    10-Q - LANTRONIX INC (0001114925) (Filer)

    2/5/26 8:13:19 AM ET
    $LTRX
    Computer Communications Equipment
    Telecommunications

    $ALVR
    $AMPE
    $AMYT
    $ATEN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BREXAFEMME issued to SCYNEXIS, INC

    Submission status for SCYNEXIS, INC's drug BREXAFEMME (ORIG-1) with active ingredient IBREXAFUNGERP has changed to 'Approval' on 06/01/2021. Application Category: NDA, Application Number: 214900, Application Classification: Type 1 - New Molecular Entity

    6/2/21 11:20:46 AM ET
    $SCYX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for BREXAFEMME issued to SCYNEXIS, INC

    Submission status for SCYNEXIS, INC's drug BREXAFEMME (SUPPL-1) with active ingredient IBREXAFUNGERP has changed to 'Approval' on 06/01/2021. Application Category: NDA, Application Number: 214900, Application Classification: Type 1 - New Molecular Entity

    6/2/21 9:57:42 AM ET
    $SCYX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for POSIMIR

    Submission status for DURECT CORP's drug POSIMIR (ORIG-1) with active ingredient BUPIVACAINE has changed to 'Approval' on 02/01/2021. Application Category: NDA, Application Number: 204803, Application Classification: Type 3 - New Dosage Form

    2/2/21 7:24:30 AM ET
    $DRRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALVR
    $AMPE
    $AMYT
    $ATEN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    A10 Networks to Host Investor Day on February 19, 2026

    Event to detail A10's long-term growth framework across Legacy Networking, Next-Generation Networking, and Security, to include Live Webcast and Replay A10 Networks (NYSE:ATEN), a leading provider of secure application services and solutions, today announced it will host an Investor Day in San Francisco on Thursday, February 19, 2026, at the Fairmont San Francisco. The Company's executive leadership team will outline A10's long-term growth framework across Legacy Networking, Next-Generation Networking, and Security. The event will include a live webcast and replay and is intended to provide investors with a deeper view into A10's strategy, portfolio evolution, and financial priorities.

    2/6/26 4:01:00 PM ET
    $ATEN
    Computer Communications Equipment
    Telecommunications

    Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium

    Procedural success was achieved in 100% of evaluable patients at 6 months and 96% in 12 months Pulse Biosciences, Inc. (NASDAQ:PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced late-breaking clinical data from the nPulse Cardiac Catheter first-in-human feasibility study. The study demonstrates successful treatment of atrial fibrillation in 150 patients with rapid procedure times and minimal adverse effects. The data were presented today at the 31st Annual AF Symposium 2026 meeting, taking place February 5-7, 2026, in Boston, MA. Key study findings include: 100% procedural success of

    2/5/26 7:00:00 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    Drone Survey Operations Drive Scalable Growth in Drones as a Service (DaaS)

    NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Survey Operations delivered through a Drones as a Service (DaaS) model are quickly becoming a preferred solution for industries that rely on accurate, real-time data. Construction, infrastructure, mining, agriculture, and energy companies are increasingly using drones to perform land surveys, site mapping, and inspections faster and at a lower cost than traditional methods. Instead of owning and operating their own drone fleets, customers can access advanced aerial surveying on demand, improving safety, reducing project timelines, and gaining higher-quality data to support better decision-making. Active Compa

    2/5/26 9:35:00 AM ET
    $DPRO
    $LTRX
    $ONDS
    Aerospace
    Industrials
    Computer Communications Equipment
    Telecommunications

    $ALVR
    $AMPE
    $AMYT
    $ATEN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Maclin Todd transferred by will 134 shares) and bought $38,775 worth of shares (266 units at $145.77), increasing direct ownership by 20% to 2,400 units (SEC Form 4)

    4 - KIMBERLY CLARK CORP (0000055785) (Issuer)

    2/6/26 5:27:22 PM ET
    $KMB
    Containers/Packaging
    Consumer Discretionary

    Chief Executive Officer La Thi L bought $305,000 worth of shares (50,000 units at $6.10), increasing direct ownership by 12% to 480,726 units (SEC Form 4)

    4 - Corsair Gaming, Inc. (0001743759) (Issuer)

    11/26/25 4:42:53 PM ET
    $CRSR
    Computer peripheral equipment
    Technology

    Director Hanish Arnold C bought $3,740 worth of shares (5,000 units at $0.75) (SEC Form 4)

    4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)

    11/24/25 5:08:13 PM ET
    $SLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALVR
    $AMPE
    $AMYT
    $ATEN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on Plus Therapeutics with a new price target

    Lake Street initiated coverage of Plus Therapeutics with a rating of Buy and set a new price target of $2.00

    2/3/26 8:52:26 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    Globus Medical upgraded by Needham with a new price target

    Needham upgraded Globus Medical from Hold to Buy and set a new price target of $112.00

    1/30/26 6:55:35 AM ET
    $GMED
    Medical/Dental Instruments
    Health Care

    Mizuho initiated coverage on Pulse Biosciences with a new price target

    Mizuho initiated coverage of Pulse Biosciences with a rating of Outperform and set a new price target of $25.00

    1/30/26 6:44:12 AM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    $ALVR
    $AMPE
    $AMYT
    $ATEN
    Financials

    Live finance-specific insights

    View All

    A10 Networks Reports Financial Results for the Fourth Quarter and Full-Year of 2025

    Company Delivers Record Revenue and Profitability for 2025 A10 Networks, Inc. (NYSE:ATEN), a leading provider of secure application services and solutions, today announced financial results for its fourth quarter and full-year ended December 31, 2025. Fourth Quarter 2025 Financial Summary Record quarterly revenue of $80.4 million. GAAP gross margin of 78.7%; non-GAAP gross margin of 80.8%. GAAP net income of $9.9 million, or $0.14 per diluted share, non-GAAP net income of $19.1 million, or $0.26 per diluted share. The Company returned $11.2 million to investors, having repurchased 406 thousand shares during the quarter at an average price of $17.02 per share for a total of $

    2/4/26 4:06:00 PM ET
    $ATEN
    Computer Communications Equipment
    Telecommunications

    Lantronix Reports Fiscal Second Quarter 2026 Financial Results

    Net Revenue of $29.8 Million GAAP EPS of ($0.03) Non-GAAP EPS of $0.04 Increases FY26 Drone Revenue Expectation to a range of $8 Million-$12 Million, up from the prior range of $5 Million-$10 Million IRVINE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ:LTRX), a global leader in compute and connectivity IoT solutions powering Edge AI applications, today reported results for the fiscal second quarter ended Dec. 31, 2025. Management Commentary "We continued our momentum into the second quarter through disciplined execution, delivering financial results within our guidance range," said Saleel Awsare, president and CEO of Lantronix. "Execution across our Edge AI strategy

    2/4/26 4:05:00 PM ET
    $LTRX
    $SPAI
    Computer Communications Equipment
    Telecommunications
    Industrial Specialties
    Health Care

    Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026

    Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced it will report business updates and financial results for the fourth quarter and full year 2025 after market close on Thursday, February 19, 2026. Company management will host a corresponding conference call beginning at 1:30pm PT / 4:30pm ET. Investors interested in listening to the conference call may do so by dialing 1-800-715-9871 from the U.S. or 1-646-307-1963 internationally and providing Conference ID 7647402. A live and recorded webcast of the event will be available on the Pulse Bioscie

    2/4/26 4:05:00 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    $ALVR
    $AMPE
    $AMYT
    $ATEN
    Leadership Updates

    Live Leadership Updates

    View All

    Corinex Appoints George Reznik as Chief Operating Officer to Accelerate Global Expansion

    VANCOUVER, BC, Feb. 2, 2026 /PRNewswire/ - Corinex, a global leader in Broadband-over-Power-Line (BPL) technology, announced the appointment of George Reznik as Chief Operating Officer. Mr. Reznik is an entrepreneurial, operational, and strategic executive leader. He has a track record of growing top-line revenue, bottom-line performance, and market share while building, commercializing, and scaling global technology companies.Corinex is accelerating the transformation of electricity networks, turning existing power line infrastructure into high-capacity, secure communications networks. This helps utilities accelerate grid modernization, integrate low-carbon technologies at scale, and increa

    2/2/26 12:30:00 PM ET
    $LTRX
    Computer Communications Equipment
    Telecommunications

    Acadia Healthcare Appoints Debbie Osteen as Chief Executive Officer

    Reaffirms Full-Year 2025 Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced that Debra K. Osteen, former Board member and former Chief Executive Officer of Acadia, has been appointed CEO, effective immediately. Osteen, who has also been appointed as a member of the Board, succeeds Chris Hunter, who is departing the Company and its Board of Directors. Reeve Waud, Chairman of Acadia's Board of Directors, said, "As Acadia continues to take decisive steps to optimize its growth investments and existing portfolio amidst ongoing macro headwinds facing many healthcare providers, the Board believes now is the right time to transition leadership. D

    1/20/26 8:00:00 AM ET
    $ACHC
    $UHS
    Medical Specialities
    Health Care
    Hospital/Nursing Management

    VALUE LINE, INC. DECLARES A QUARTERLY CASH DIVIDEND OF $0.325 PER COMMON SHARE AND APPOINTS NEW BOARD MEMBER

    NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Value Line, Inc. (NASDAQ: VALU) announced today that its Board of Directors declared on January 16, 2026 a quarterly cash dividend of $0.325 per common share, payable on February 10, 2026, to stockholders of record on January 26, 2026. The Company has 9,387,957 shares of common stock outstanding as of January 16, 2026. The Company also announced that the Board has appointed Dr. Alexander J. Swistel to its Board of Directors and as a member of the Board's Audit Committee.         Value Line is a leading provider of investment research. The Value Line Investment Survey is one of the most widely used sources of independent equity research.        

    1/16/26 3:20:00 PM ET
    $VALU
    Investment Managers
    Finance

    $ALVR
    $AMPE
    $AMYT
    $ATEN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by NACCO Industries Inc.

    SC 13D/A - NACCO INDUSTRIES INC (0000789933) (Subject)

    12/17/24 3:53:36 PM ET
    $NC
    Coal Mining
    Energy

    Amendment: SEC Form SC 13D/A filed by NACCO Industries Inc.

    SC 13D/A - NACCO INDUSTRIES INC (0000789933) (Subject)

    12/17/24 3:38:59 PM ET
    $NC
    Coal Mining
    Energy

    Amendment: SEC Form SC 13D/A filed by NACCO Industries Inc.

    SC 13D/A - NACCO INDUSTRIES INC (0000789933) (Subject)

    12/17/24 3:38:47 PM ET
    $NC
    Coal Mining
    Energy